Generics

Tagged stories

The Long View

The Expensive Shortage Ended. The Cheap One Is Still Running.

Tirzepatide came off the FDA shortage list in December 2024 and semaglutide in February 2025. Ifosfamide, a decades-old chemotherapy used in curative regimens, is three months into a shortage the FDA expects to run into autumn and European regulators into 2027. Same country, same regulator, same manufacturing base.

By Thomas Gutierrez · 7 hours ago

Health

The Drug Shortage Is a Manufacturing Problem Wearing a Pharmacy Uniform

The medicines that run short are almost never the expensive new ones. They are decades-old generics made on thin margins in a handful of plants, where a single inspection failure removes a meaningful share of world supply.

By Thomas Gutierrez · August 29, 2026